Medical Cannabis for Trigeminal Neuralgia: The Suicide Disease and Its Treatment

Trigeminal Neuralgia: The Most Painful Condition Known to Medicine

• Trigeminal neuralgia (TN) is a chronic pain condition affecting the trigeminal nerve
• Described as electric shock-like facial pain, it is rated among the most severe pains known
• Attacks can last seconds to minutes and may be triggered by eating, speaking, or touching the face
• TN affects approximately 27 per 100,000 people — with a higher incidence in older adults
• First-line treatment is carbamazepine; surgical options include microvascular decompression and radiosurgery

Trigeminal neuralgia has historically been called the ‘suicide disease’ due to the unbearable nature of its pain and the psychological toll it takes on patients. Many individuals cannot work, eat comfortably, or engage socially during active periods. When medication becomes ineffective or causes intolerable side effects, medical cannabis is increasingly considered as part of the treatment plan.

How Medical Cannabis Addresses Neuropathic Facial Pain

• The trigeminal nerve contains CB1 receptors that modulate pain transmission
• THC acts on central pain pathways to reduce the perceived intensity of neuropathic pain signals
• CBD reduces neuroinflammation around damaged nerve roots
• Cannabis may extend the analgesic effect of carbamazepine, allowing dose reduction
• Cannabis addresses associated anxiety and sleep disruption that carbamazepine does not

Cannabinoids work on multiple levels in neuropathic facial pain — reducing central sensitisation, modulating trigeminal nucleus activity, and dampening inflammatory processes around affected nerve tissue. While TN-specific cannabis trials are limited, neuropathic pain trials consistently show benefit, and TN shares the same underlying pain mechanisms as other cannabinoid-responsive neuropathies.

UK Access for Trigeminal Neuralgia Patients

• TN falls squarely within the neuropathic pain indication recognised by UK prescribers
• Patients should bring a neurology diagnosis and documented treatment history
• Cannabis is most commonly prescribed for Type 2 TN (constant background pain) rather than purely paroxysmal Type 1
• Sublingual oils provide consistent blood levels — important for preventing breakthrough attacks
• Inhaled flower may be used as rescue medication during acute episodes

Patients with trigeminal neuralgia can access medical cannabis through UK licensed private clinics. Given the severity of TN, clinicians typically fast-track assessment for patients with documented treatment-refractory disease. The prescribing doctor will evaluate your current medications, particularly carbamazepine interactions, before designing a cannabis protocol.

Living with TN and Using Medical Cannabis Safely

• Cannabis should complement, not replace, proven first-line TN treatments unless medically advised
• Tracking attack frequency and intensity in a pain diary is essential for monitoring response
• Cannabis may interfere with carbamazepine metabolism — always inform your neurologist
• Avoid high-THC doses if anxiety is a significant feature of your TN experience
• Surgical options remain available and should not be ruled out if cannabis provides only partial relief

For trigeminal neuralgia patients who have not achieved adequate pain control with medication or who are awaiting surgery, medical cannabis offers a meaningful bridge therapy. The combination of background pain reduction and improved sleep quality can significantly improve quality of life. A collaborative approach between your neurologist and cannabis prescriber ensures the safest and most effective outcome.